FOXO TECHNOLOGIES INC. Costs and Expenses, Related Party
FOXO TECHNOLOGIES INC. (FOXO) reported Costs and Expenses, Related Party of $2.68 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-06-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:CostsAndExpensesRelatedParty · last filed 2024-06-28
- FOXO TECHNOLOGIES INC. costs and expenses, related party for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- FOXO TECHNOLOGIES INC. costs and expenses, related party for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- FOXO TECHNOLOGIES INC. costs and expenses, related party for the quarter ending 2023-06-30 was $595.00K, a 59.96% decline year-over-year.
- FOXO TECHNOLOGIES INC. costs and expenses, related party for the quarter ending 2023-03-31 was $2.02M.
- FOXO TECHNOLOGIES INC. costs and expenses, related party for fiscal 2023 was $2.68M, a 52.63% decline from fiscal 2022.
- FOXO TECHNOLOGIES INC. costs and expenses, related party for fiscal 2022 was $5.65M.
| Period end | Costs and Expenses, Related Party 3 month | Costs and Expenses, Related Party 6 month | Costs and Expenses, Related Party 9 month | Costs and Expenses, Related Party 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-06-06 | $0.00 derived: sum of 2 quarters · filed 2024-06-06 | $595.00K derived: sum of 3 quarters · filed 2024-06-06 | $2.68M 10-K · filed 2024-06-06 |
| 2023-09-30 | $0.00 10-Q/A · filed 2024-06-04 | $595.00K derived: sum of 2 quarters · filed 2024-06-04 | $2.68M 10-Q/A · filed 2024-06-04 | $4.69M derived: sum of 4 quarters · filed 2024-06-28 |
| 2023-06-30 | $595.00K 10-Q · filed 2023-08-10 | $2.68M 10-Q · filed 2023-08-10 | $4.69M derived: sum of 3 quarters · filed 2024-06-28 | $6.78M derived: sum of 4 quarters · filed 2024-06-28 |
| 2023-03-31 | $2.02M 10-Q · filed 2024-06-28 | $4.10M derived: sum of 2 quarters · filed 2024-06-28 | $6.18M derived: sum of 3 quarters · filed 2024-06-28 | $7.67M derived: sum of 4 quarters · filed 2024-06-28 |
| 2022-12-31 | $2.08M derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-06-06 | $4.16M derived: sum of 2 quarters · filed 2024-06-06 | $5.65M derived: sum of 3 quarters · filed 2024-06-06 | $5.65M 10-K · filed 2024-06-06 |
| 2022-09-30 | $2.08M 10-Q/A · filed 2024-06-04 | $3.57M derived: sum of 2 quarters · filed 2024-06-04 | $3.57M 10-Q/A · filed 2024-06-04 | |
| 2022-06-30 | $1.49M 10-Q · filed 2023-08-10 | $1.49M 10-Q · filed 2023-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |